HCM
IRWD icon

Harvey Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Harvey Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-67,939
Closed -$673K – 80
2013
Q3 		$673K Buy
+67,939
New +$666K 0.34% 42

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Harvey Capital Management's IRWD Position: Q4 2013 in Review

Harvey Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2013, closing a stake of 67,939 shares — an estimated $673K sold.

Harvey Capital Management first reported a position in IRWD in Q3 2013 and held it in 1 quarter. The position peaked at $673K in Q3 2013. 124 funds tracked by Wall St. Rank hold IRWD as of Q4 2013.

  • Harvey Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Harvey Capital Management sold 67,939 Ironwood Pharmaceuticals shares in Q4 2013, an estimated $673K.
  • Harvey Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • Harvey Capital Management's Ironwood Pharmaceuticals position peaked at $673K in Q3 2013.
  • 124 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2013.

Based on Harvey Capital Management's 13F filing for Q4 2013, filed 15 Jan 2014.